Lv6
2740 积分 2024-11-04 加入
A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020
1个月前
已完结
[Efficacy and clinical remission in patients with severe asthma and blood eosinophil counts ≥150 cells/μl treated with benralizumab: a sub-analysis of the Phase 3 MIRACLE study]
4个月前
已完结
Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma
4个月前
已完结
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
4个月前
已完结
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
4个月前
已完结
JCS 2026 Guideline on the Management of Infective Endocarditis
4个月前
已完结
Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trial
6个月前
已完结
Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus
7个月前
已完结
Recaticimab in adult heterozygous familial hypercholesterolaemia (REMAIN-3): a multicentre, randomized, double-blind, placebo-controlled Phase 3 study
9个月前
已完结
皖公网安备34019202002308
